Biotricity, News

Biotricity expands development of its Cardiac AI Cloud Platform with Data Ecosystem of over 360 billion Heartbeats

Biotricity Inc. (Biotricity) today announced the expanding development of its future Cardiac AI Cloud platform. The new platform is focused on predictive monitoring to help assist physicians and users to identify issues before they occur, supporting earlier interventions, reducing readmissions, and lowering healthcare costs. Biotricity’s product portfolio is already one of the most comprehensive remote cardiac monitoring portfolios globally. This expansion will further enhance its existing products while providing additional advantages.


Read More

News, Wedge Networks

Wedge Networks announces its partner DLS has been awarded the Government of Canada SLSA for 5 years

Wedge Networks (Wedge) announced that it’s partner DLS Technology Corporation [DLS] has been awarded a Government of Canada Supply Arrangement under the Software and Licensing Supply Arrangement [SLSA ] for an additional 5 (five) years, through to 2028.  This SA underscores DLS’s commitment to providing modern and secure solutions to our government clients. Government of Canada departments, Crown Corporations, and Government Agencies requiring software, licensing, and solutions support can procure through this vehicle with the confidence that they will receive the most favored pricing from trusted DLS and our partners.


Read More

Biotricity, News

Biotricity achieves $14 Million Revenue Run Rate in August 2023

Biotricity Inc. (Biotricity) today reported that it achieved a record $14 million annualized revenue run rate in August, extending its growth by over eight percent from the previously announced $13 million run rate.  In its Corporate Impact Report published last spring, Biotricity described both “better patient outcomes and substantial cost savings” for patients using its devices.


Read More

Biotricity, Healthcare, News

Biotricity expands its proprietary AI model and deepens relationship with Amazon AWS and Google’s tensor flow for remote cardiac care applications

Biotricity Inc. (Biotricity) today announced its strengthened relationships with Amazon and Google. The Company is expanding its AI technology development in remote cardiac care, leveraging its proprietary AI technology to provide a suite of predictive monitoring tools to enhance new disease profiling, improve patient management, and revolutionize the healthcare industry for disease prevention.


Read More

Biotricity, News

Biotricity regains Nasdaq listing compliance

Biotricity Inc. (Biotricity) today announced that it received notice from The NASDAQ Stock Market LLC (NASDAQ) on July 18, 2023 informing that it has regained compliance with the minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2) for continued listing on The NASDAQ Capital Market. Consequently, Biotricity is now in compliance with all applicable listing standards and its common stock will continue to be listed on The NASDAQ Capital Market.


Read More

Biotricity, News

Biotricity announces reverse stock split

Biotricity Inc. (Biotricity) today announced that it will effect a reverse stock split of its common stock.  Biotricity expects its common stock to begin trading on a split-adjusted basis on the Nasdaq Capital Market as of the commencement of trading on July 3, 2023.  The reverse stock split was approved by the Board of Directors of the Company and is intended to increase the per share trading price of the Company’s common stock to satisfy the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market.


Read More

Healthcare, News

Seaspring signs definitive agreement for joint venture with Asep Inc. for regulatory approval and commercialisation of sepsis diagnosis technology in Bahrain and MENA

Pursuant to the signing of a Letter of Intent (LOI) in December 2022, Seaspring W.L.L. (“Seaspring”) and Asep Medical Holdings Inc. (“Asep Inc.” or the “Company”) have signed a definitive agreement (“agreement”) for a joint venture to advance regulatory approval and commercialization of the Company’s sepsis diagnosis technology (SepsetER TM) in the Kingdom of Bahrain and the Middle East and North Africa (MENA).  The terms of the definitive agreement include the formation of a 50/50 joint venture (name to be determined) whereby Seaspring will contribute the capital required (a near-term estimate of USD $5 million that is open-ended
and subject to change) by the joint venture to conduct its business operations (regulatory approval, sales and distribution) and Asep Inc. through its subsidiary Sepset Biosciences Inc., will provide the licensing rights for the use of the SepsetER technology in the Kingdom of Bahrain, Algeria, Egypt, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Qatar, Saudi Arabia, Syria, Tunisia, United Arab Emirates and Yemen.


Read More

News, Wedge Networks

Wedge Networks announces general availability of its innovative, Continuous Learning Analytics and Threat Intelligence Engine, WedgeIQ™ Nucleation Edition at Asia Tech Singapore

Wedge Networks (Wedge) today announced the General Availability (GA) of WedgeIQ™ Nucleation Edition, an innovative, continuous machine-learning based Security Operations, Incident, and Event Management (SIEM) and analytics engine, at Asia Tech x Singapore, Asia’s premier tech event.  Developed as a licensable component of the advanced WedgeARP™ software platform, WedgeIQ™ Nucleation Edition offers a potent response to today’s pressing cybersecurity challenges, particularly the increasingly sophisticated, never-before-seen malware that outmaneuvers current defense systems where Wedge’s patented continuous AI engines are continuously learning to respond to such attacks.


Read More

Biotricity, News

Biotricity reaches $13M revenue run rate in April 2023 on accelerating growth

Biotricity Inc. (Biotricity) today reported that it reached a record $13 million annualized revenue run rate in April,  further extending its growth by over eight percent from the $12 million run rate it announced for March 2023.  In its Corporate Impact Report published earlier this month, Biotricity described both “better patient outcomes and substantial cost savings” for patients using its devices.


Read More

News, Wedge Networks

Wedge Networks teams up with Edgecore Networks to offer next-generation network security WedgeCND™ Add-on now available on Edgecore ecCLOUD

Wedge Networks Inc. (“Wedge”) today announced that Edgecore Networks, a leading provider of traditional and open network solutions for enterprises, data centers, and telecommunication service providers, has partnered with Wedge Networks to offer a next-generation network security solution to its customers. Wedge Networks’ Wedge Cloud Network Defense (WedgeCND™), is a cloud-managed security service designed to provide comprehensive security protection.

 


Read More

1 2 3
Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Youtube
Consent to display content from - Youtube
Vimeo
Consent to display content from - Vimeo
Google Maps
Consent to display content from - Google
Spotify
Consent to display content from - Spotify
Sound Cloud
Consent to display content from - Sound